Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/11/1997 | WO1997046678A1 Nucleic acids and polypeptides related to presenilin |
12/11/1997 | WO1997046677A1 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO |
12/11/1997 | WO1997046676A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
12/11/1997 | WO1997046675A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses |
12/11/1997 | WO1997046674A1 Spruce budworm antifreeze proteins, genes and methods of using same |
12/11/1997 | WO1997046673A2 Inhibition of hiv-1 replication by antisense rna expression |
12/11/1997 | WO1997046669A1 Transgenic mammals lacking expression of amylin |
12/11/1997 | WO1997046668A1 Novel peptide, process for the production of the same, and use of the same |
12/11/1997 | WO1997046666A1 Modified small rna viruses |
12/11/1997 | WO1997046664A1 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
12/11/1997 | WO1997046661A2 A human radioresistance/cell cycle progression gene |
12/11/1997 | WO1997046588A1 Cellular internalization of pigr stalk and associated ligands |
12/11/1997 | WO1997046587A2 Ob PROTEIN BINDING PROTEIN |
12/11/1997 | WO1997046586A1 Novel human receptor type tyrosine kinase-like protein |
12/11/1997 | WO1997046585A2 Fragments of leptin (ob protein) |
12/11/1997 | WO1997046584A1 Exendin analogues, processes for their preparation and medicaments containing them |
12/11/1997 | WO1997046583A1 Novel feline cytokine protein |
12/11/1997 | WO1997046582A1 Meningococcal vaccine |
12/11/1997 | WO1997046581A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
12/11/1997 | WO1997046579A1 Neuropeptide y agonists |
12/11/1997 | WO1997046578A1 Peptide derivatives |
12/11/1997 | WO1997046573A1 Method of inhibiting antigen processing, chimeric proteins reflecting this method, and methods of expressing those proteins |
12/11/1997 | WO1997046572A1 Transgenic animals expressing artificial epitope-tagged proteins |
12/11/1997 | WO1997046547A1 β-SHEET NUCLEATING PEPTIDOMIMETICS |
12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
12/11/1997 | WO1997046257A1 A method for enhancing long-term memory in a subject and uses thereof |
12/11/1997 | WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
12/11/1997 | WO1997046251A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
12/11/1997 | WO1997046250A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
12/11/1997 | WO1997046248A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
12/11/1997 | WO1997046223A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
12/11/1997 | WO1997046206A2 Human thyrotropin receptor compositions and use thereof |
12/11/1997 | WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer |
12/11/1997 | WO1997046079A1 Seed plants exhibiting inducible early reproductive development and methods of making same |
12/11/1997 | WO1997046078A1 Maize and cauliflower apetala1 gene products and nucleic acid molecules encoding same |
12/11/1997 | WO1997046077A1 Seed plants exhibiting early reproductive development and methods of making same |
12/11/1997 | WO1997041443A3 Method for screening compounds |
12/11/1997 | WO1997041252A3 Dna, rna and a protein useful for detection of a mycobacterial infection |
12/11/1997 | WO1997041228A3 Use of the green fluorescent protein as a screenable marker for plant transformation |
12/11/1997 | WO1997038082A3 Hypertonia gene |
12/11/1997 | WO1997029319A3 Bioluminescent novelty items |
12/11/1997 | WO1997026920A3 Conjugate for differentiating between diseased and healthy tissues |
12/11/1997 | WO1997022700A3 Grapevine leafroll virus proteins and their uses |
12/11/1997 | DE19622783A1 Isolierung der Biosynthesegene für Pseudo-Oligosaccharide aus Streptomyces glaucescens GLA.O und ihre Verwendung Isolation of the biosynthetic genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O and their use |
12/11/1997 | CA2261637A1 A human radioresistance/cell cycle progression gene |
12/11/1997 | CA2258720A1 Human thyrotropin receptor compositions and use thereof |
12/11/1997 | CA2257943A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
12/11/1997 | CA2257531A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
12/11/1997 | CA2257474A1 Ob protein binding protein |
12/11/1997 | CA2257424A1 Neuropeptide y agonists |
12/11/1997 | CA2257389A1 Virus-like particles useful as a vector for delivering nucleic acid |
12/11/1997 | CA2257243A1 Polynucleotides from human adult pbmc encoding secreted proteins |
12/11/1997 | CA2257240A1 Fragments of leptin (ob protein) |
12/11/1997 | CA2257149A1 Nematode-inducible plant gene promoter |
12/11/1997 | CA2257119A1 Exendin analogues, processes for their production and pharmaceutical preparations containing them |
12/11/1997 | CA2257117A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
12/11/1997 | CA2257108A1 Novel peptides and production and use thereof |
12/11/1997 | CA2257074A1 A method for enhancing long-term memory in a subject and uses thereof |
12/11/1997 | CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer |
12/11/1997 | CA2256523A1 Galanin receptor galr2 |
12/11/1997 | CA2256522A1 Polynucleotides encoding secreted proteins |
12/11/1997 | CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells |
12/11/1997 | CA2256484A1 Vectors comprising sar elements |
12/11/1997 | CA2256464A1 Tumor necrosis factor-related polypeptide |
12/11/1997 | CA2256449A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies |
12/11/1997 | CA2256304A1 Cellular internalization of pigr stalk and associated ligands |
12/11/1997 | CA2254862A1 Metabotropic gaba[b] receptors, receptor-specific ligands and their uses |
12/11/1997 | CA2254819A1 Inhibition of hiv-1 replication by antisense rna expression |
12/11/1997 | CA2253262A1 Transgenic animals expressing artificial epitope-tagged proteins |
12/11/1997 | CA2252417A1 Peptide derivatives |
12/11/1997 | CA2251536A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
12/11/1997 | CA2228618A1 Novel feline cytokine protein |
12/11/1997 | CA2228444A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
12/11/1997 | CA2228301A1 Materials and methods for detection of breast cancer |
12/10/1997 | EP0811696A2 Method to obtain nucleotide sequence using randomly primed amplification |
12/10/1997 | EP0811695A2 Mutant S182(PS-1) genes |
12/10/1997 | EP0811691A1 Antibody againts alpha-chain of human interleukin 5 receptor |
12/10/1997 | EP0811688A2 Staphylococcus aureus RNase P |
12/10/1997 | EP0811686A2 Human platelet-derived growth factor receptors |
12/10/1997 | EP0811685A2 Human platelet-derived growth factor receptors |
12/10/1997 | EP0811684A2 Oxytocin receptor portion or variant, and dna coding for the same |
12/10/1997 | EP0811683A1 Antibodies to human gastrin-releasing peptide precursor and use thereof |
12/10/1997 | EP0811385A2 Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease |
12/10/1997 | EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta |
12/10/1997 | EP0811078A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth |
12/10/1997 | EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF |
12/10/1997 | EP0811074A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
12/10/1997 | EP0811072A1 Transgenic animals as model of psoriasis |
12/10/1997 | EP0811069A1 Chimeric adenoviral fiber protein and methods of using same |
12/10/1997 | EP0811067A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
12/10/1997 | EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
12/10/1997 | EP0811065A1 Antagonists of interleukin-15 |
12/10/1997 | EP0811064A2 Mpl ligand analogs |
12/10/1997 | EP0811063A2 Chemokine receptors 88-2b ckr-3] and 88c and their antibodies |
12/10/1997 | EP0811062A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof |
12/10/1997 | EP0811061A1 Multiple-tumor aberrant growth genes |
12/10/1997 | EP0811060A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS |
12/10/1997 | EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/10/1997 | EP0811058A1 A process for the preparation of factor ix from biological sources |
12/10/1997 | EP0811056A1 Peptides for tissue and cell culture media |